Minjeong Kang

机构：Korea Advanced Institute of Science and Technology, Iowa State University · ORCID：0000-0002-6329-5323

发表论文 47 篇 · 总被引 988 次 · h-index 16

代表论文

• Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer (2023 · Nature Communications · 被引 117)
• Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy (2022 · Nature Nanotechnology · 被引 66)
• Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics (2023 · Nature Nanotechnology · 被引 48)
• Systems and synthetic biology-driven engineering of live bacterial therapeutics (2023 · Frontiers in Bioengineering and Biotechnology · 被引 35)
• Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells (2024 · Nature Biomedical Engineering · 被引 29)
• An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy (2025 · Nature Cancer · 被引 21)